Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Novel Disinfectant Technology Shown to Provide Rapid and Persistent Effectiveness in Eliminating COVID-19 Virus and Other Harmful Hospital Acquired Pathogens.

Chicago, Illinois, United States - 10-05-2022 (PR Distribution™) -

Hospital acquired infections (HAIs) affect more than one million patients annually resulting in over 100,000 deaths while costing health systems more than $40 billion each year. Harmful pathogens can live up to 7 months on environmental surfaces and common pathways between patients, workers and such surfaces are frequent vectors for HAI transmission. 

Researchers at the University of Michigan have developed an effective, durable and safe-to-use disinfectant coating that can rapidly kill a variety of pathogens. The substance is an all-natural compound whose active ingredient is derived from plant based essential oils which can be easily applied either via spray or brush without damaging the underlying surface.

A recently published study assessing its efficacy demonstrated a 99.9% kill rate of gram negative and gram positive (including MRSA) bacteria in addition to the SARS-CoV-2 virus when microorganisms were exposed to coated surfaces.(1) These results were achieved within a few minutes and in some cases a few seconds of exposure. In addition, treated surfaces maintained antimicrobial efficacy over six months of air exposure as well as when subjected to substantial mechanical, chemical and thermal duress. Even after its effectiveness diminished, the coating could be recharged by applying fresh material thereby renewing is antimicrobial activity.

“The coating could be a game changer in traditionally germ-laden public spaces like airports and hospitals,” said Anish Tuteja, professor at the University of Michigan and lead investigator.

The coating technology has been exclusively licensed to EnviraShield Health, LLC for application in all healthcare settings. EnviraShield Health is a privately held company with next generation antimicrobial coatings that combine a patent-pending polymeric formulation with broad spectrum anti-microbial activity. EnviraShield’s focus is to enhance patient care by creating safer healthcare environments that reduce the risk of infection caused by contaminated surface contact.

For Additional Information Contact: 

David Holly, Chief Commercialization Officer,?Envirashield Health 

Phone: (312) 285-5154

Email: dholly@triunity-ventures.com

www.envirashieldhealth.com

(1). Dhyani A, Repetto T, Bartikofsky D, et. al. Surfaces with instant and persistent antimicrobial efficacy against bacteria and SARS-CoV-2. Matter. 2022;8:018. https://doi.org/10.1016/j.matt.2022.08.018.


Disclaimer: The information and views set out in this press release are those of the author(s) and do not necessarily reflect the official opinion of PR Distribution, its staff, its associates, its partners or the media outlet(s) that this press release may be distributed on. Responsibility for the information and views set out in this press release lies entirely with the author(s). If you have any questions(s) pertaining to this matter, please contact the author(s) directly at: dholly@triunity-ventures.com

Media Contacts:

Company Name: EnviraShield Health, LLC
Full Name: David Holly, Chief Commercialization Officer
Phone: (312) 285-5154
Email Address: Send Email
Website: http://www.envirashieldhealth.com

For the original news story, please visit https://www.prdistribution.com/news/novel-disinfectant-technology-shown-to-provide-rapid-and-persistent-effectiveness-in-eliminating-covid-19-virus-and-other-harmful-hospital-acquired-pathogens/9330824.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.